Literature DB >> 32203367

Coronavirus vaccines: five key questions as trials begin.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  Infection; Virology

Mesh:

Substances:

Year:  2020        PMID: 32203367     DOI: 10.1038/d41586-020-00798-8

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.

Authors:  Hana Weingartl; Markus Czub; Stefanie Czub; James Neufeld; Peter Marszal; Jason Gren; Greg Smith; Shane Jones; Roxanne Proulx; Yvonne Deschambault; Elsie Grudeski; Anton Andonov; Runtao He; Yan Li; John Copps; Allen Grolla; Daryl Dick; Jody Berry; Shelley Ganske; Lisa Manning; Jingxin Cao
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

  1 in total
  16 in total

1.  A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world.

Authors:  Nicola Bellomo; Richard Bingham; Mark A J Chaplain; Giovanni Dosi; Guido Forni; Damian A Knopoff; John Lowengrub; Reidun Twarock; Maria Enrica Virgillito
Journal:  Math Models Methods Appl Sci       Date:  2020-08-19       Impact factor: 3.817

2.  Recovery during a crisis: facing the challenges of risk assessment and resilience management of COVID-19.

Authors:  Scira Menoni; Reimund Schwarze
Journal:  Environ Syst Decis       Date:  2020-05-24

3.  Primary prevention: Vaccines and the allergist-immunologist's role.

Authors:  Mitchell H Grayson
Journal:  Ann Allergy Asthma Immunol       Date:  2020-07       Impact factor: 6.347

4.  Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.

Authors:  Benjamin Israelow; Eric Song; Tianyang Mao; Peiwen Lu; Amit Meir; Feimei Liu; Mia Madel Alfajaro; Jin Wei; Huiping Dong; Robert J Homer; Aaron Ring; Craig B Wilen; Akiko Iwasaki
Journal:  bioRxiv       Date:  2020-05-27

5.  Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID-19.

Authors:  Kevin J McHugh
Journal:  Bioeng Transl Med       Date:  2020-05-13

Review 6.  COVID-19: Therapeutics and Their Toxicities.

Authors:  Michael A Chary; Alexander F Barbuto; Sudeh Izadmehr; Bryan D Hayes; Michele M Burns
Journal:  J Med Toxicol       Date:  2020-04-30

7.  Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.

Authors:  Arif Musa; Kasim Pendi; Areio Hashemi; Elizabeth Warbasse; Sarkis Kouyoumjian; Jenna Yousif; Emily Blodget; Susan Stevens; Besma Aly; David A Baron
Journal:  West J Emerg Med       Date:  2020-05-20

8.  The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.

Authors:  Anindita Banerjee; Rakesh Sarkar; Suvrotoa Mitra; Mahadeb Lo; Shanta Dutta; Mamta Chawla-Sarkar
Journal:  JMIR Bioinform Biotech       Date:  2020-09-07

9.  Stability analysis in COVID-19 within-host model with immune response.

Authors:  Alexis Erich S Almocera; Griselda Quiroz; Esteban A Hernandez-Vargas
Journal:  Commun Nonlinear Sci Numer Simul       Date:  2020-11-03       Impact factor: 4.260

10.  Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.

Authors:  Mohammad Shaminur Rahman; Mohammad Rafiul Islam; Mohammad Nazmul Hoque; Abu Sayed Mohammad Rubayet Ul Alam; Masuda Akther; Joynob Akter Puspo; Salma Akter; Azraf Anwar; Munawar Sultana; Mohammad Anwar Hossain
Journal:  Transbound Emerg Dis       Date:  2020-10-06       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.